ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,085
-0,05%
Bitcoin
66 324,11
-0,47%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Atherogenics (MM) (AGIX)

  7. Atherogenics (MM) (AGIX) Actualités

AGIX

Atherogenics (AGIX)

Atherogenics (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AGIX
DateHeureSourceTitreSymboleSociété
10/10/200823h23Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AGIXAtherogenics (MM)
10/10/200823h15MarketwiredAtheroGenics Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 FilingNASDAQ:AGIXAtherogenics (MM)
10/10/200821h35Edgar (US Regulatory)Withdrawal of Registration Statement (RW)NASDAQ:AGIXAtherogenics (MM)
07/10/200814h20Edgar (US Regulatory)Atherogenics Inc - Current report filing (8-K)NASDAQ:AGIXAtherogenics (MM)
07/10/200812h51MarketwiredAtheroGenics Files for Chapter 11 BankruptcyNASDAQ:AGIXAtherogenics (MM)
11/09/200801h13MarketwiredAtheroGenics Restructures Board of DirectorsNASDAQ:AGIXAtherogenics (MM)
02/09/200817h44MarketwiredBellwetherReport.com Analyst Opinions on SCRX, AGIX, BUCY and ISILNASDAQ:AGIXAtherogenics (MM)
02/09/200814h39MarketwiredAtheroGenics Seeks to Realign Capital StructureNASDAQ:AGIXAtherogenics (MM)
25/08/200821h00Edgar (US Regulatory)Atherogenics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AGIXAtherogenics (MM)
20/08/200812h24Edgar (US Regulatory)Atherogenics Inc - Application for qualification of trust indentures (T-3)NASDAQ:AGIXAtherogenics (MM)
05/08/200813h00MarketwiredAtheroGenics Reports Second Quarter 2008 Financial ResultsNASDAQ:AGIXAtherogenics (MM)
01/08/200816h20PR Newswire (US)BeaconEquity.com Issues Technical Trade Alerts on Market Movers: AGIX, APKT, BIOS, NOVA, CNXT, CHRDNASDAQ:AGIXAtherogenics (MM)
31/07/200817h27MarketwiredBellwetherReport.com Analyst Report on HOLX, AKAM, SBUX and AGIXNASDAQ:AGIXAtherogenics (MM)
31/07/200813h00MarketwiredAtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 DiabetesNASDAQ:AGIXAtherogenics (MM)
25/07/200813h15MarketwiredAtheroGenics to Report Second Quarter 2008 Financial Results on August 5, 2008NASDAQ:AGIXAtherogenics (MM)
30/06/200815h21MarketwiredAtheroGenics Receives Notice of Non-Compliance With Listing Requirement for the NASDAQ Global MarketNASDAQ:AGIXAtherogenics (MM)
19/06/200815h20PR Newswire (US)BeaconEquity.com Issues TraderNotes on Stocks: TPIM, NSM, BRLC, AGIX, AROX, TLEO, HLYS, ABATNASDAQ:AGIXAtherogenics (MM)
10/06/200815h17MarketwiredAtheroGenics Reports Clinical Data on Novel Anti-Inflammatory Anti-Oxidant Agent, AGI-1067, at American Diabetes Association AnnNASDAQ:AGIXAtherogenics (MM)
04/06/200813h30MarketwiredAtheroGenics Announces Five Abstracts Accepted for the American Diabetes Association's 68th Annual Scientific SessionsNASDAQ:AGIXAtherogenics (MM)
23/05/200821h38Edgar (US Regulatory)Atherogenics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AGIXAtherogenics (MM)
23/05/200802h55MarketwiredAtheroGenics' ARISE Trial Results Published in The LancetNASDAQ:AGIXAtherogenics (MM)
09/05/200823h10Edgar (US Regulatory)Atherogenics Inc - Quarterly Report (10-Q)NASDAQ:AGIXAtherogenics (MM)
30/04/200820h51Marketwired/ CORRECTION - AtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008NASDAQ:AGIXAtherogenics (MM)
30/04/200816h57MarketwiredAtheroGenics to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on May 2, 2008NASDAQ:AGIXAtherogenics (MM)
24/04/200813h00MarketwiredAtheroGenics Reports First Quarter 2008 Financial ResultsNASDAQ:AGIXAtherogenics (MM)
18/04/200815h33Edgar (US Regulatory)Atherogenics Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:AGIXAtherogenics (MM)
17/04/200815h18MarketwiredAtheroGenics to Report First Quarter 2008 Financial Results on April 24, 2008NASDAQ:AGIXAtherogenics (MM)
14/04/200813h00MarketwiredAtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 DiabetesNASDAQ:AGIXAtherogenics (MM)
07/04/200822h38Edgar (US Regulatory)Atherogenics Inc - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:AGIXAtherogenics (MM)
11/03/200814h31MarketwiredAtheroGenics to Present at Lehman Brothers Global Healthcare Conference March 18, 2008NASDAQ:AGIXAtherogenics (MM)
 Showing the most relevant articles for your search:NASDAQ:AGIX

Dernières Valeurs Consultées

EU
DG
Vinci
NYSE
JPM
JP Morgan Chase
EU
AI
Air Liquide
USI
USTECH100
US Tech 100
EU
BNP
BNP Paribas
NASDAQ
MSFT
Microsoft
EU
ORA
Orange
NASDAQ
AMZN
Amazon.com
NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
EU
CAP
Capgemini
NYSE
KO
Coca Cola
COIN
BTCUSD
Bitcoin
EU
VK
Vallourec
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés